Pediatric Cardiologist
University of Alberta
University of Alberta
Dr Lisa Hornberger is a Professor of Pediatrics (Division of Cardiology) and Obstetric & Gynecology at the University of Alberta in Edmonton, the Divisional Director of Pediatric Cardiology and one of the leads of the Stollery Cardiac Program. Over the past 15 years she functioned as both the Director of the Fetal & Neonatal Cardiology Program and Section Head of Pediatric Echocardiography. She holds academic positions within the University of Alberta’s Women’s & Children’s Health Research Institute, Cardiovascular Research Center and Mazankowski Alberta Heart Institute. She has established world-class fetal cardiovascular programs at Boston Children’s Hospital, Harvard Medical School (1993-1996), University of Toronto (1996-2003), the University of California, San Francisco in collaboration with the internationally recognized UCSF Fetal Treatment Center (2003-2008), and most recently at the University of Alberta (2008-2021). For over 2 decades she has been involved in clinical, educational and research endeavors in fetal and neonatal cardiovascular health and disease. She has published over 200 peer-reviewed papers and co-authored textbooks in the clinical, population, health services and fundamental sciences focused on the early diagnosis, evolution, management and outcomes of fetal heart disease. More recently, Dr Hornberger’s research efforts have included examining strategies to improve prenatal detection of congenital heart disease, exploring the impact of the perinatal transition on critical fetal heart disease, investigating short and long-term cardiovascular changes associated with early adverse exposures (e.g.maternal diabetes, preterm birth), investigating the impact of socioeconomic status and remoteness of residence on access to care and clinical outcomes of CHD in Canada, examining the contribute of maternal vascular health and V-A coupling on pregnancy outcomes associated with maternal heart disease, and employing small and large animal models to explore the pathogenesis and etiologies of fetal cardiovascular disease and programming and the perinatal and early postnatal evolution of myocardial function.
Disclosure(s): No financial relationships to disclose
156 - FROM RESEARCH TO PRACTICE: CARDIOVASCULAR TRANSLATIONAL MEDICINE
Thursday, October 24, 2024
3:15 PM – 4:15 PM PT
Friday, October 25, 2024
3:55 PM – 4:15 PM PT